✦ LIBER ✦

Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

✍ Scribed by Wasan, Harpreet; Meade, Angela M; Adams, Richard; Wilson, Richard; Pugh, Cheryl; Fisher, David; Sydes, Benjamin; Madi, Ayman; Sizer, Bruce; Lowdell, Charles; Middleton, Gary; Butler, Rachel; Kaplan, Richard; Maughan, Tim

Book ID: 122297496
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 442 KB
Volume: 15
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(14)70106-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6006 ORAL Intermittent Chemotherapy (CT)

6006 ORAL Intermittent Chemotherapy (CT) Plus Continuous or Intermittent Cetuximab (C) in the First-line Treatment of Advanced Colorectal Cancer (aCRC): Results of the Two-arm Phase II Randomised MRC COIN-B Trial

✍ Wasan, H.; Adams, R.A.; Wilson, R.H.; Pugh, C.A.; Fisher, D.; Madi, A.; Sizer, B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Intermittent versus continuous oxaliplat

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

✍ Richard A Adams; Angela M Meade; Matthew T Seymour; Richard H Wilson; Ayman Madi 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 420 KB